HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gravell, M. Articles by Tourtellotte, W. W. Search for Related Content PubMed PubMed Citation Articles by Gravell, M. Articles by Tourtellotte, W. W.

PAM cell assay as a test for multiple-sclerosis associated agent

Infectious Diseases Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Bethesda, Maryland (Drs. Gravell, Madden and Sever, Mrs. Hamilton, and Mr. Kiefer), and the Neurology Service, Veterans' Administration, Wadsworth Hospital Center, Los Angeles, California (Dr. Tourtellotte).

Contrary to previous reports, no evidence for a multiple sclerosis-associated agent (MSAA) was obtained when coded brain samples from multiple sclerosis patients and controls were tested in PAM cells.

Reprint requests should be addressed to Dr. Gravell, Infectious Diseases Branch, National Institute of Neurological and Communicative Disorders and Stroke, National Institutes of Health, Building 36, Room 5D-06, Bethesda, MD 20014.

Accepted for publication May 23, 1978.